the counts are in!
There is an IFCC "reference" method:
L to P
The best LDH method as a tumour marker is
L to P (Tietz and others).
I agree with David Bullock we should use just one method
It would appear that L to P is the method of choice and for patient safety reasons we should all use L to P.
martin
From: Clinical biochemistry discussion list [mailto:[log in to unmask]]
On Behalf Of Myers Martin (LTHTR)
Sent: 05 September 2012 11:36
To: [log in to unmask]
Subject: Lactate Dehydrogenase
Do people have a view on whether lactate dehydrogenase should be measured by lactate to pyruvate or pyruvate to lactate, especially if the LDH assay is primarily being used as
a tumour marker?
thanks
martin
This message and any files transmitted with it are confidential and intended solely for the individual(s) addressed. If you have received this e-mail in error then please note that disclosing, copying, distributing or retaining this message or any part
of it is strictly prohibited. Please notify the sender immediately and delete it from your system. Any views or opinions presented are solely those of the author and do not necessarily represent those of Lancashire Teaching Hospitals NHS Foundation Trust.
The Trust accepts no liability for any damage caused by any virus transmitted with this e-mail, so although it has been virus checked before transmission, the recipient should also check for the presence of viruses. The information contained in this email
may be subject to public disclosure under the NHS Code of Openness or the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this email and any subsequent reply cannot be guaranteed. http://www.lancsteachinghospitals.nhs.uk
------ACB discussion List Information-------- This is an open discussion list for the academic and clinical community working in clinical biochemistry. Please note, archived messages are public and can be viewed via the internet. Views expressed are those of
the individual and they are responsible for all message content. ACB Web Site
http://www.acb.org.uk Green Laboratories Work
http://www.laboratorymedicine.nhs.uk List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
This message and any files transmitted with it are confidential and intended solely for the individual(s) addressed. If you have received this e-mail in error then please note that disclosing, copying, distributing or retaining this message or any part of it is strictly prohibited. Please notify the sender immediately and delete it from your system. Any views or opinions presented are solely those of the author and do not necessarily represent those of Lancashire Teaching Hospitals NHS Foundation Trust. The Trust accepts no liability for any damage caused by any virus transmitted with this e-mail, so although it has been virus checked before transmission, the recipient should also check for the presence of viruses. The information contained in this email may be subject to public disclosure under the NHS Code of Openness or the Freedom of Information Act 2000. Unless the information is legally exempt from disclosure, the confidentiality of this email and any subsequent reply cannot be guaranteed. http://www.lancsteachinghospitals.nhs.uk
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
